Searchable abstracts of presentations at key conferences in endocrinology

ea0081p211 | Thyroid | ECE2022

SARS-CoV-2 Vaccine-Associated Subacute Thyroiditis: Insights from a Systematic Review

Ippolito Silvia , Gallo Daniela , Rossini Alessandro , Patera Bohdan , Lanzo Nicola , Fazzino Gaia Francesca Maria , Piantanida Eliana , Laura Tanda Maria

Introduction: subacute thyroiditis (SAT) is an inflammatory disease of the thyroid gland causing transient thyrotoxicosis, characterized by neck pain and symptoms of thyroid hormones excess. Viral infections are considered the main trigger of SAT. SAT has also been described after vaccination against H1 N1 vaccine, seasonal influenza virus vaccine, Human Papillomavirus vaccine, and hepatitis B vaccination; more recently, a rising number of cases of SAT following SARS-CoV-2 vac...

ea0081p734 | Thyroid | ECE2022

Short and long-term efficacy of image-guided laser and radiofrequency ablation therapies: a prospective monocentric and single-operator study

Francesca Birtolo Maria , Antonini Simone , Ierace Tiziana , Cristofolini Giacomo , Maida Giulia , Mazziotti Gherardo , Lania Andrea , Solbiati Luigi

Background: In the last decades mini-invasive techniques have been proposed to reduce costs and complications of emithyroidectomy and thyroidectomy, both for benign nodular goiter and thyroid microcarcinoma, and image-guided laser and radiofrequency ablation are the most used.Purpose: To investigate short and long-term efficacy of image-guided laser and radiofrequency ablation as therapy options for benign nodular goiter.Methods: F...

ea0081p513 | Late-Breaking | ECE2022

The first reported pregnancy and birth by a patient affected by Alström Syndrome: a case report

Marozio Luca , Bertschy Gianluca , Canuto Emilie M. , Maffei Pietro , Milan Gabriella , Dassie Francesca , Cosma Stefano , Benedetto Chiara

Background: Alström Syndrome (ALMS, OMIM 203800) is an ultra-rare disease caused by autosomal recessive mutations of the ALMS1 gene (2p13). ALMS is characterized by double sensory impairment and systemic comorbidities, including hyperandrogenism in female patients. Fertility issue and conception have not been systematically studied.Case: This case report describes the pregnancy and birth by an ALMS patient with mild phenotype, characterized...

ea0081ep569 | Endocrine-Related Cancer | ECE2022

Novel pathogenetic mutation of MEN1 gene causing hyperparathyroidism, pancreatic glucagonoma, adrenal adenoma, and collagenomas

Pitino Rosa , Vimercati Davide , Pizzolitto Francesca , Mollero Edoardo Luigi Maria , Daffara Tommaso , Ferrero Alice , Boldorini Renzo , Caputo Marina , Prodam Flavia

Background: Multiple endocrine neoplasia type 1 (MEN1) is a rare hereditary autosomal dominant tumor syndrome caused by inactivating mutations of the tumor suppressor gene MEN1 which encodes the protein menin. It is characterized by the occurrence of tumors involving two or more endocrine glands, primarily parathyroid, entero-pancreatic, and anterior pituitary, as well as non-endocrine neoplasms. Glucagonomas occur in fewer than 3% of patients with MEN1, causing hyper...

ea0084op-05-24 | Oral Session 5: Autoimmunity | ETA2022

Sirolimus for graves’ orbitopathy: A novel drug for the management of patients with moderate-to-severe graves’ orbitopathy?

Lanzolla Giulia , Novella Maglionico Maria , Comi Simone , Menconi Francesca , Posarelli Chiara , Figus Michele , Marcocci Claudio , Marino' Michele

Background: Sirolimus is an immunosuppressive drug with anti-fibrotic and anti-proliferative activities. In vitro, sirolimus inhibits differentiation of orbital fibroblasts from patients with Graves’ orbitopathy (GO), suggesting a possible use in clinical practice.Methods: We performed a retrospective investigation aimed at evaluating the effects of sirolimus as a second-line treatment for moderate-to-severe, active GO, compared with methyl...

ea0084ps1-02-16 | Hypothyroidism | ETA2022

Evolution of congenital hypothyroidism with in situ thyroid gland in children and adolescents: Clinical and biochemical features at diagnosis and after retesting

Bagattini Brunella , Agretti Patrizia , De Marco Giuseppina , Ferrarini Eleonora , Orsolini Francesca , Sciarroni Elisabetta , Tonacchera Massimo , Montanelli Lucia , Pignata Luisa

Background: In recent years, increasing cases of congenital hypothyroidism (CH) with in situ thyroid gland (GIS) are identified. Outcome of children affected from CH with normally sited thyroid of normal size is still unknown. The objective of our study is to describe the natural history of this specific form of CH.Methods: We retrospectively evaluated clinical, biochemical and instrumental data of 89 patients with diagnosis of CH and GIS, refer...

ea0084ps2-06-50 | Hypothyroidism Treatment | ETA2022

TSH levels assessment in hypothyroid patients treated with liquid or tablet l-thyroxine

Antonelli Alessandro , Martina Ferrari Silvia , Elia Giusy , Ragusa Francesca , Rosaria Paparo Sabrina , Mazzi Valeria , Botrini Chiara , Fallahi Poupak

Objective: Tablet levothyroxine (L-T4) is the common used therapy for hypothyroidism. In order to assess a good compliance to the therapy, treated patients are monitored with the execution of annual thyroid hormonal test. The stability of TSH levels in hypothyroid patients (with no malabsorption issues), treated with liquid L-T4, compared to that of the patients treated with tablet L-T4, remained a poorly understood topic. This study has the purpose to deepen this issue.<p...

ea0084ps2-07-63 | Graves’ Disease 1 | ETA2022

Corticosteroids and mycophenolic acid have a synergistic effect on chemokines secretion in orbital cells from patients with graves’ ophthalmopathy

Martina Ferrari Silvia , Fallahi Poupak , Ragusa Francesca , Elia Giusy , Rosaria Paparo Sabrina , Patrizio Armando , Balestri Eugenia , Antonelli Alessandro

Objective: An enhancement of the response rate has been recently showed in patients with Graves’ ophthalmopathy (GO) treated with corticosteroids and mycophenolic acid. In GO, retro-orbital cells showed a cytokine-induced secretion of Th1 and Th2 chemokines. Since no data are present in literature about the effect of corticosteroids and mycophenolic acid on the chemokines secretion in GO orbital cells, we aim to deepen out this topic.Methods: We est...

ea0084ps2-09-85 | Thyroid Hormone ACTION | ETA2022

3-Iodothyroacetic acid release in a mouse model of ischemia-induced synaptic dysfunction

Ricardi Caterina , Bertolini Andrea , Tozzi Francesca , Polini Beatrice , Rutigliano Grazia , Zucchi Riccardo , Chiellini Grazia , Saba Alessandro , Origlia Nicola

The endogenous thyroid hormone derivative 3-iodothyronamine (T1AM), and its metabolite 3-iodothyroacetic acid (TA1) are known to stimulate learning and induce hyperalgesia in mice. Recently, it has been demonstrated that exogenous T1AM is able to rescue synaptic impairment after transient ischemia in the entorhinal cortex (EC), a brain area crucially involved in learning and memory, and early affected during Alzheimer’s disease. However, i...

ea0084ps3-14-127 | Thyroid Cancer CLINICAL 2 | ETA2022

Dominant benign thyroid nodules (BTN) treated with percutaneous microwave termoablation (PMWT): an effective tool to decrease thyroid nodule volume

Criscuoli Benedetta , Manni Carlo , Alborino Salvatore , Salvatori Fabio , Losito Raffaele , Ferrara Gerardo , Elisei Daniele , Accardi Roberto , Capoccetti Francesca

Objectives: Image-guided thermal-ablation (LTA; RFA) are well established therapy options in selected BTN. PMWT is a mini-invasive technique recently applied in thyroid disease; aim of this work is investigate its effectiveness as treatment in BTN.Methods: From May 2021, 45 patients (30 F, 15 M, Aged 37-90, Mean 55,8) with BTN symptomatic/in growing, refusing/non eligible to surgery were enrolled. Inclusion criteria: nodule diameter ≥ 2 cm, mainly ...